Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults
Clinical trial NCT05463068 · COMPLETED
Trial details
- NCT number
- NCT05463068
- Sponsor
- Novavax
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-11
- Primary completion
- 2022-08-17
- Enrollment
- 911
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.